Skip to main content
Premium Trial:

Request an Annual Quote

BG Medicine Files for IPO on Euronext Amsterdam Exchange

NEW YORK (GenomeWeb News) - BG Medicine today said it has filed for an initial public offering of its shares on the Euronext Amsterdam Exchange.
 
The biomarker and diagnostics developer said it has filed a registration statement with the US Securities and Exchange Commission but has not yet determined the number of shares it plans to issue and it has not set an opening price for its common stock.
 
BG Medicine said it plans to trade on the Euronext Amsterdam market by the New York Stock Exchange's Euronext under the symbol BGMDX.
 
Cowen International and Fortis will serve as global coordinators and book-runners and Leerink Swann & Co. will co-manage the offering.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.